Haselmeier acquires drug manufacturing license and now offers assembly, labelling and packaging services to pharmaceutical and biotechnology companies

Stuttgart, February 11, 2019 – Haselmeier is a leading solution provider for self-injection devices. As an innovative and strategic partner for pharmaceutical and biotechnology companies, Haselmeier develops and produces customized, unique self-injection systems that are used worldwide. The quality, reliability and ease of use of these high-tech products play a key role in the therapeutic efficiency and quality of life of patients.

Haselmeier has been in possession of an allowance to manufacture pharmaceuticals since December 2018, which is done at the production site in Buchen, Odenwald, in accordance with §13 of the Medicines Act (Arzneimittelgesetz – AMG) or according to Art. 40 of Directive 2001/83/EC. Haselmeier can now offer pharmaceutical and biotechnological companies an assembly, labelling and packaging service.

Konrad Betzler, Chief Quality Officer of Haselmeier: “I am pleased that, after extensive preparatory work and in close coordination with the responsible GMP supervisory authority, we have now received the manufacturing permit”. 

Haselmeier will in future assemble the cartridges supplied by customers for the respective therapies with the injection pens as well as label and package the combination products. This service also includes the manufacture of batches for stability testing. Haselmeier thus offers important complete solutions, for example for pharmaceutical companies in the production of small and medium-sized series for clinical studies as well as for biotech start-ups.

About Haselmeier
Haselmeier is a leading developer and manufacturer of innovative self-injection devices that feature company designs and state-of-the-art technology. Haselmeier has more than four decades of experience in the field of medical devices. Through the years, the company has built up a top-class planning and development team that is responsible for the design, planning and industrialization of our innovative self-injection systems – and thus manufactures successful products that are used by pharmaceutical and biotechnology companies worldwide.

Haselmeier with headquarters in Switzerland, employs around 200 people worldwide. Our company has sales offices in Europe, the United States and India. The Haselmeier-products are manufactured in state-of-the-art production facilities in Buchen, Odenwald (Germany), Dnešice (Czech Republic) and Bengaluru (India).

Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

CAMBRIDGE, United States, May 2, 2018 – Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, today announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines.
Continue reading “Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration”

Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer)

Konrad Betzler was appointed the new Chief Quality Officer (CQO) of the entire Haselmeier Group in October 2017 with responsibility for quality management, quality assurance and all regulatory matters worldwide. As a member of the Group Executive Board, he continues to lead the Pharmaceutical Manufacturing division as Chief Pharmaceutical Officer (CPO).

Continue reading “Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer)”

Haselmeier AG appoints Paul Jansen as Senior Advisor and Member of the Board of Directors

The well-respected and listened to member of the medical device community, Paul Jansen, started in his new position as senior advisor on February 1, 2017. This appointment is a perfect fit to serve the objectives of Haselmeier AG as the innovation organization within the Haselmeier Group.

Continue reading “Haselmeier AG appoints Paul Jansen as Senior Advisor and Member of the Board of Directors”

May we introduce: the award-winning D-Flex. Just one.

Haselmeier has not even officially presented its latest innovation and the D-Flex. Just one. has already won an award: The especially flexible disposable pen D-Flex has been given the GOOD DESIGN™ Award. However, the D-Flex stands out in the market primarily thanks to its uniqueness. No comparable product can be deployed so flexibly and at the same time deliver patient safety.

Continue reading “May we introduce: the award-winning D-Flex. Just one.”

TÜV certification for the Bengaluru facility

Haselmeier is pleased to announce that its newest production facility in Bengaluru (India) received its official certification from TÜV SÜD on 21st September 2016. Haselmeier is now in a position to supply the Asian market more easily and more effectively with medication dosage systems and, as a result, significantly improve life for patients.  

Continue reading “TÜV certification for the Bengaluru facility”

Press Releases